Viewing Study NCT03423992


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-01-05 @ 5:12 PM
Study NCT ID: NCT03423992
Status: UNKNOWN
Last Update Posted: 2021-06-15
First Post: 2018-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Sponsor: Xuanwu Hospital, Beijing
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module